These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29735615)

  • 1. Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina.
    Khatiwoda P; Proeschold-Bell RJ; Meade CS; Park LP; Proescholdbell S
    N C Med J; 2018; 79(3):149-155. PubMed ID: 29735615
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Opioid Overdose.
    Babu KM; Brent J; Juurlink DN
    N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
    Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
    J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.
    Binswanger IA; Koester S; Mueller SR; Gardner EM; Goddard K; Glanz JM
    J Gen Intern Med; 2015 Dec; 30(12):1837-44. PubMed ID: 26055224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Opioid Epidemic in NC: Progress, Challenges, and Opportunities.
    Kansagra SM; Cohen MK
    N C Med J; 2018; 79(3):157-162. PubMed ID: 29735617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B; Gilmour J; Deering D
    Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm Reduction Strategies for the Opiod Crisis.
    Castillo T
    N C Med J; 2018; 79(3):192-194. PubMed ID: 29735629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents.
    Majer JM; Beasley C; Stecker E; Bobak TJ; Norris J; Nguyen HM; Ogata M; Siegel J; Wiedbusch E; Dovale I; Gelfman N; Callahan S; Jason LA
    Community Ment Health J; 2018 Jul; 54(5):571-577. PubMed ID: 29302767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting Opioid Users Where They Are: A Service Referral Approach to Law Enforcement.
    Paul L
    N C Med J; 2018; 79(3):172-173. PubMed ID: 29735622
    [No Abstract]   [Full Text] [Related]  

  • 15. Caring for patients with opioid use disorder in the hospital.
    Donroe JH; Holt SR; Tetrault JM
    CMAJ; 2016 Dec; 188(17-18):1232-1239. PubMed ID: 27647616
    [No Abstract]   [Full Text] [Related]  

  • 16. Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada.
    Weicker SA; Hayashi K; Grant C; Milloy MJ; Wood E; Kerr T
    Drug Alcohol Depend; 2019 Dec; 205():107672. PubMed ID: 31706251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.
    Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H
    J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities.
    Roncero C; Domínguez-Hernández R; Díaz T; Fernández JM; Forcada R; Martínez JM; Seijo P; Terán A; Oyagüez I
    Adicciones; 2015 Sep; 27(3):179-89. PubMed ID: 26437312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensing a Naloxone Kit at Hospital Discharge: A Retrospective QI Project.
    Train MK; Patel N; Thapa K; Pasho M; Acquisto NM
    Am J Nurs; 2020 Dec; 120(12):48-52. PubMed ID: 33214374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate use disorders and overdose: Medical students' experiences, satisfaction with learning, and attitudes toward community naloxone provision.
    Tobin H; Klimas J; Barry T; Egan M; Bury G
    Addict Behav; 2018 Nov; 86():61-65. PubMed ID: 29198489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.